These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 24668309

  • 1. Zoledronic acid in combination with alfacalcidol has additive effects on trabecular microarchitecture and mechanical properties in osteopenic ovariectomized rats.
    Khajuria DK, Razdan R, Mahapatra DR.
    J Orthop Sci; 2014 Jul; 19(4):646-56. PubMed ID: 24668309
    [Abstract] [Full Text] [Related]

  • 2. Additive effects of zoledronic acid and propranolol on bone density and biochemical markers of bone turnover in osteopenic ovariectomized rats.
    Khajuria DK, Razdan R, Mahapatra DR.
    Rev Bras Reumatol; 2015 Jul; 55(2):103-12. PubMed ID: 25582996
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development, in vitro and in vivo characterization of zoledronic acid functionalized hydroxyapatite nanoparticle based formulation for treatment of osteoporosis in animal model.
    Khajuria DK, Razdan R, Mahapatra DR.
    Eur J Pharm Sci; 2015 Jan 23; 66():173-83. PubMed ID: 25444840
    [Abstract] [Full Text] [Related]

  • 5. The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis.
    Shiraishi A, Miyabe S, Nakano T, Umakoshi Y, Ito M, Mihara M.
    BMC Musculoskelet Disord; 2009 Jun 15; 10():66. PubMed ID: 19527501
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
    Hornby SB, Evans GP, Hornby SL, Pataki A, Glatt M, Green JR.
    Calcif Tissue Int; 2003 Apr 15; 72(4):519-27. PubMed ID: 12574877
    [Abstract] [Full Text] [Related]

  • 9. Effects of combined treatment with eldecalcitol and alendronate on bone mass, mechanical properties, and bone histomorphometry in ovariectomized rats: a comparison with alfacalcidol and alendronate.
    Sugimoto M, Futaki N, Harada M, Kaku S.
    Bone; 2013 Jan 15; 52(1):181-8. PubMed ID: 23041510
    [Abstract] [Full Text] [Related]

  • 10. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
    Gasser JA, Ingold P, Venturiere A, Shen V, Green JR.
    J Bone Miner Res; 2008 Apr 15; 23(4):544-51. PubMed ID: 18072878
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Therapeutic effect of risedronate on cancellous and cortical bone in ovariectomized osteopenic rats: a comparison with the effects of alfacalcidol.
    Iwamoto J, Seki A, Takeda T, Sato Y, Yamada H, Yeh JK.
    Exp Anim; 2006 Jul 15; 55(4):333-42. PubMed ID: 16880680
    [Abstract] [Full Text] [Related]

  • 13. Effect of systemic administered zoledronic acid on osseointegration of a titanium implant in ovariectomized rats.
    Dikicier E, Karaçaylı Ü, Dikicier S, Günaydın Y.
    J Craniomaxillofac Surg; 2014 Oct 15; 42(7):1106-11. PubMed ID: 24530079
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Novel therapeutic intervention for osteoporosis prepared with strontium hydroxyapatite and zoledronic acid: In vitro and pharmacodynamic evaluation.
    Khajuria DK, Vasireddi R, Trebbin M, Karasik D, Razdan R.
    Mater Sci Eng C Mater Biol Appl; 2017 Feb 01; 71():698-708. PubMed ID: 27987763
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M, Mori H, Kayasuga R, Ochi Y, Kawada N, Yamada H, Kishikawa K.
    Bone; 2008 Nov 01; 43(5):894-900. PubMed ID: 18687415
    [Abstract] [Full Text] [Related]

  • 19. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A, Tanaka M, Nozaki K, Mori M, Fukushima S, Mori H, Shiroya T, Nakamura T.
    Bone; 2013 Jul 01; 55(1):189-97. PubMed ID: 23486179
    [Abstract] [Full Text] [Related]

  • 20. Effect of combined teriparatide and monthly minodronic acid therapy on cancellous bone mass in ovariectomized rats: a bone histomorphometry study.
    Iwamoto J, Seki A, Sato Y.
    Bone; 2014 Jul 01; 64():88-94. PubMed ID: 24727162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.